What Panacea Biotec Limited said it won
Orders Panacea Biotec Limited announced to the exchange, gathered from its own filings.
2 announcements between 11 April 2026 and 5 August 2026, newest first. Each line is the company's own sentence, taken from the filing it attached.
River doesn't rate these or add them into a forecast. That reading is yours.
Across the whole exchange in October 2026, companies announced ₹12,583 Cr of orders — 94 filings from 68 companies.
5 AUG 2026
US$ 8.205 millionWe are now delighted to inform you that in terms of the aforesaid Long-Term Agreement, the Company has received Letter of Award for supply of bOPV in 10 and 20 dose presentation worth ~US$ 8.205 million (~Rs.78.24 Crore) in Calendar Year 2028.
from UNICEF · execution: Calendar Year 2028
11 APR 2026
INR 20.79 CroreAs per the LOA, the Company will supply Diphtheria and Tetanus Vaccine (Absorbed) for Adults and Adolescents IP (“Td Vaccine”) in several tranches to CMSS starting from September / October 2026 till November / December 2028 for the value aggregating to INR 20.79 Crore.
from Central Medical Services Society · execution: From September / October 2026 till November / December 2028
Email me when Panacea Biotec Limited announces the next one.
No account. One line per filing. Unsubscribe in one click.
Hold PANACEABIO? Write down why, and River brings it back when the next order lands.
Everything above is the company's side of the ledger. The side nobody keeps is yours — what you expected the day you bought, written down before the outcome was known.
Keep my reason for PANACEABIOWhat other companies have won
PowericaPOWERICAKalpataru ProjectsKPILRudrabhishekREPLLarsen & ToubroLTRefex IndustriesREFEXTransrail LightingTRANSRAILLPVP VenturesPVPRailtel CorporationRAILTEL
Every company on recordCorporate announcements filed by the company with the National Stock Exchange of India. River reproduces what was filed and links to it. River is not an investment adviser and does not give investment advice.